1-3 of 3
Yu Wu
Close
Sort by
Journal Articles

A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML

Clinical Trials & Observations
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, Depei Wu, Xiaofei Yang, Suning Chen
Journal: Blood Advances
Blood Adv (2024) 8 (4): 889–894.
https://doi.org/10.1182/bloodadvances.2023012006
Published: 2024
Includes: Supplemental data
Journal Articles

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Clinical Trials & Observations
Nathanael R. Fillmore, Jennifer La, Julie Tsu-Yu Wu, June K. Corrigan, Westyn Branch-Elliman, Paul Monach, Mary T. Brophy, Nhan V. Do, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6767–6770.
https://doi.org/10.1182/bloodadvances.2023011063
Published: 2023
Journal Articles

ALCAM-EGFR interaction regulates myelomagenesis

Hongmei Luo, Dan Zhang, Fangfang Wang, Qiang Wang, Yu Wu, Maling Gou, Yiguo Hu, Wenyan Zhang, Jingcao Huang, Yuping Gong, Ling Pan, Tianshu Li, Pan Zhao, Danfeng Zhang, Ying Qu, Zhigang Liu, Tao Jiang, Yang Dai, Tingting Guo, Jiang Zhu, Lingqun Ye, Li Zhang, Weiping Liu, Qing Yi, Yuhuan Zheng
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5269–5282.
https://doi.org/10.1182/bloodadvances.2021004695
Published: 2021
Includes: Supplemental data